'Milestone' study shows drug may halve cancer deaths and cut heart attack risks

An "exciting" new study has revealed a drug that could help reduce the risk of heart attacks and cut cancer deaths.

Mon, 28 Aug, 2017 - 08:49

An "exciting" new study has revealed a drug that could help reduce the risk of heart attacks and cut cancer deaths.

More than 10,000 patients took part in a trial using the anti-inflammatory Canakinumab, the results of which were presented at the European Society of Cardiology meeting in Barcelona, Spain.

More in this section

France’s prime minister pleads for support to reduce debts ahead of key vote

Israel demolishes high-rise building in Gaza City as part of ramped-up offensive

Palestinian gunmen open fire at Jerusalem bus stop, killing six

Courts Heathrow Place: Barcelona, Spain Place: Boston Person: Paul Ridker Person: Ridker Person: Gary Gibbons Organisation: Brigham and Women's Hospital Organisation: National Heart, Lung, and Blood Institute Organisation: NHLBI Organisation: Novartis Pharmaceuticals

Lawyers for the US president had asked for a new trial (Alex Brandon/AP)

Appeals court upholds E Jean Carroll’s defamation judgment against Trump

READ NOW

'Milestone' study shows drug may halve cancer deaths and cut heart attack risks

Unlimited access. Half the price.

Appeals court upholds E Jean Carroll’s defamation judgment against Trump

Latest

Most Read